BioMed valued at $14.6 billion in deal for sale from one Blackstone fund to another



The ticker and trading information for Blackstone Group is displayed at the post where it is traded on the floor of the New York Stock Exchange


© Reuters/Brendan McDermid
The ticker and trading information for Blackstone Group is displayed at the post where it is traded on the floor of the New York Stock Exchange


(Reuters) – Blackstone Real Estate Partners and co-investors have agreed to sell BioMed Realty for $14.6 billion to a group led by existing BioMed investors, Blackstone Group Inc said on Thursday.

Blackstone had agreed to buy BioMed Realty, a supplier of office space to healthcare companies, in late 2015 in a deal valued at $8 billion. (https://reut.rs/341V5a3)

Video: Europe’s Top Fintech Unicorn: Klarna CEO on $10.6 billion valuation, fundraising mega-round (CNBC)

Europe’s Top Fintech Unicorn: Klarna CEO on $10.6 billion valuation, fundraising mega-round

UP NEXT

UP NEXT

Blackstone said on Thursday it is commencing a “go-shop” process on behalf of BioMed’s current investors, with the recapitalization expected to close within five business days after the process concludes.

(Reporting by Kanishka

Read More